Cite
HARVARD Citation
Khan, A. et al. (2018). FNAC positivity- A predictor of axillary disease burden in neoadjuvant chemotherapy patients. European journal of surgical oncology. 44 (6), pp. 898-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Khan, A. et al. (2018). FNAC positivity- A predictor of axillary disease burden in neoadjuvant chemotherapy patients. European journal of surgical oncology. 44 (6), pp. 898-. [Online].